TRPM8 biology and medicinal chemistry

Current Topics in Medicinal Chemistry

Volumn 11, Issue 17, 2011, Pages 2237-2252

  Defalco, Jeff ^a   Duncton, Matthew A J ^a   Emerling, Daniel ^a  

^a EVOTEC AG   (Germany)

Author keywords

Agonist; Antagonist; Icilin; Ligand; Menthol; TRP; TRPM8

Indexed keywords

1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; 1 (2 HYDROXYPHENYL) 4 (3 NITROPHENYL) 1,2,3,6 TETRAHYDROPYRIMIDIN 2 ONE; 1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1,10 PHENANTHROLINE; AG 3 5; CAPSAZEPINE; CINEOLE; CINNAMALDEHYDE; CINNAMIC ACID DERIVATIVE; CLOTRIMAZOLE; CPS 113; CPS 369; D 3263; ECONAZOLE; ISOMENTHOL; LIGAND; LYSOPHOSPHOLIPID; MENTHOL; MENTHONE; N (4 TERT BUTYLPHENYL) 4 (3 CHLORO 2 PYRIDINYL) 1 PIPERAZINECARBOXAMIDE; NEOMENTHOL; RN 1747; SB 452533; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8 AGONIST; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8 ANTAGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; WS 12; WS 148; WS 30;

ALLODYNIA; ARTICLE; COLD; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; IN VIVO STUDY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR UPREGULATION; STRUCTURE ACTIVITY RELATION; THERMOREGULATION; TREATMENT INDICATION;

CHEMISTRY, PHARMACEUTICAL; HUMANS; LIGANDS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TRPM CATION CHANNELS;

EID: 80052195065     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802611796904933     Document Type: Article

References (167)

1. Tsavaler, L.; Shapero, M. H.; Morkowski, S.; Laus, R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res., 2001, 61, 3760-3769.
2. McKemy, D. D.; Neuhausser, W. M.; Julius, D. Identification of a cold receptor reveals a general role for TRP channels in thermosen-sation. Nature, 2002, 416, 52-58.
3. Peier, A. M.; Moqrich, A.; Hergarden, A. C.; Reeve, A. J.; Andersson, D. A.; Story, G. M.; Earley, T. J.; Dragoni, I.; McIntyre, P.; Bevan, S.; Patapoutian, A. A TRP channel that senses cold stimuli and menthol. Cell, 2002, 108, 705-715.
4. Hui, K.; Guo, Y.; Feng, Z. P. Biophysical properties of menthol-activated cold receptor TRPM8 channels. Biochem. Biophys. Res. Commun., 2005, 333, 374-382.
5. Voets, T.; Owsianik, G.; Janssens, A.; Talavera, K.; Nilius, B. TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli. Nat. Chem. Biol., 2007, 3, 174-182.
6. Andersson, D. A.; Chase, H. W.; Bevan, S. TRPM8 activation by menthol, icilin, and cold is differentially modulated by intracellular pH. J. Neurosci., 2004, 24, 5364-5369.
7. Liu, B.; Qin, F. Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. J. Neurosci., 2005, 25, 1674-1681.
8. Rohács, T.; Lopes, C. M.; Michailidis, I.; Logothetis, D. E. PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat. Neurosci., 2005, 8, 626-634.
9. 2+-independent phospholipase A2-dependent gating of TRPM8 by lysophospholipids. J. Biol. Chem., 2006, 281, 40174-40182.
10. Andersson, D. A.; Nash, M.; Bevan, S. Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsatu-rated fatty acids. J. Neurosci., 2007, 27, 3347-3355.
11. Bidaux, G.; Roudbaraki, M.; Merle, C.; Crépin, A.; Delcourt, P.; Slomianny, C.; Thebault, S.; Bonnal, J.L.; Benahmed, M.; Cabon, F.; Mauroy, B.; Prevarskaya, N. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional an-drogen receptor requirement. Endocr. Relat. Cancer., 2005, 12, 367-382.
12. Zhang, L.; Barritt, G. J. TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? En-docr. Relat. Cancer, 2006, 13, 27-38.
13. Zhang, L.; Barritt, G. J. Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Res., 2004, 64, 8365-8373.
14. Beck, B.; Bidaux, G.; Bavencoffe, A.; Lemonnier, L.; Thebault, S.; Shuba, Y.; Barrit, G.; Skryma, R.; Prevarskaya, N. Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators. Cell Calcium, 2007, 41, 285-294.
15. Bidaux, G.; Flourakis, M.; Thebault, S.; Zholos, A.; Beck, B.; Gkika, D.; Roudbaraki, M.; Bonnal, J.L.; Mauroy, B.; Shuba, Y.; Skryma, R.; Prevarskaya, N. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function. J. Clin. Invest., 2007, 117, 1647-1657.
16. Thebault, S., Lemonnier, L., Bidaux, G., Flourakis, M., Baven-coffe, A., Gordienko, D., Roudbaraki, M., Delcourt, P., Panchin, Y., Shuba, Y., Skryma, R., Prevarskaya, N Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells. J. Biol. Chem., 2005, 280, 39423-29435.
17. Mahieu, F.; Owsianik, G.; Verbert, L.; Janssens, A.; De Smedt, H.; Nilius B.; Voets, T. TRPM8-independent menthol-induced Ca2+ release from endoplasmic reticulum and Golgi. J. Biol. Chem., 2007, 282, 3325-3336.
18. Sabnis, A. S.; Shadid, M.; Yost, G. S.; Reilly, C. A. Human lung epithelial cells express a functional cold-sensing TRPM8 variant. Am. J. Respir. Cell. Mol. Biol., 2008, 39, 466-474.
19. Bors, E. H.; Blinn, K. A. Spinal reflex activity from the vesical mucosa in paraplegic patients. A.M.A. Arch. Neurol. Psychiatry, 1957, 78, 339-354.
20. Geirsson, G.; Lindström, S.; Fall, M. The bladder cooling reflex and the use of cooling as stimulus to the lower urinary tract. J. Urol., 1999, 162, 1890-1896.
21. Karashima, Y.; Damann, N.; Prenen, J.; Talavera, K.; Segal, A.; Voets, T.; Nilius, B. Bimodal action of menthol on the transient receptor potential channel TRPA1. J. Neurosci., 2007, 27, 9874-9884.
22. Du, S.; Araki, I.; Kobayashi, H.; Zakoji, H.; Sawada, N., Takeda, M. Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology, 2008, 72, 450-455.
23. Mukerji, G.; Yiangou, Y.; Corcoran, S. L.; Selmer, I. S.; Smith, G. D.; Benham, C. D.; Bountra, C.; Agarwal, S. K.; Anand, P. Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. B.M.C. Urol., 2006, 6, 6.
24. Lashinger, E. S.; Steiginga, M. S.; Hieble, J. P.; Leon, L. A.; Gardner, S.D.; Nagilla, R.; Davenport, E. A.; Hoffman, B. E.; Lap-ing, N. J.; Su, X. AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome. Am. J. Physiol. Renal. Physiol., 2008, 295, F803-810.
25. Story, G. M.; Peier, A. M.; Reeve, A. J.; Eid, S. R.; Mosbacher, J.; Hricik, T. R.; Earley, T. J.; Hergarden, A. C.; Andersson, D. A.; Hwang, S. W.; McIntyre, P.; Jegla, T.; Bevan, S.; Patapoutian, A. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell, 2003, 112, 819-829.
26. Kobayashi, K.; Fukuoka, T.; Obata, K.; Yamanaka, H.; Dai, Y.; Tokunaga, A.; Noguchi, K. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with a-d/c-fibers and colocalization with trk receptors. J. Comp. Neurol., 2005, 493, 596-606.
27. Proudfoot, C. J.; Garry, E. M.; Cottrell, D. F.; Rosie, R.; Anderson, H.; Robertson, D. C.; Fleetwood-Walker, S. M.; Mitchell, R. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr. Biol., 2006, 16, 1591-1605.
28. Xing, H.; Chen, M.; Ling, J.; Tan, W.; Gu, J.G. TRPM8 mechanism of cold allodynia after chronic nerve injury. J. Neurosci., 2007, 27, 13680-13690.
29. Frederick, J.; Buck, M. E.; Matson, D. J.; Cortright, D. N. Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. Biochem. Biophys. Res. Commun., 2007, 358, 1058-1064.
30. Obata, K.; Katsura, H.; Mizushima, T.; Yamanaka, H.; Kobayashi, K.; Dai, Y.; Fukuoka, T.; Tokunaga, A.; Tominaga, M.; Noguchi, K. TRPA1 induced in sensory neurons contributes to cold hyperal-gesia after inflammation and nerve injury. J. Clin. Invest., 2005, 115, 2393-2401.
31. Caspani, O.; Zurborg, S.; Labuz, D.; Heppenstall, P. A. The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One, 2009, 4, e7383.
32. Katsura, H.; Obata, K.; Mizushima, T.; Yamanaka, H.; Kobayashi, K.; Dai, Y.; Fukuoka, T.; Tokunaga, A.; Sakagami, M.; Noguchi, K. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp. Neurol., 2006, 200, 112-123.
33. Bautista, D. M.; Siemens, J.; Glazer, J. M.; Tsuruda, P. R.; Bas-baum, A. I.; Stucky, C. L.; Jordt, S. E.; Julius, D. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature, 2007, 448, 204-208.
34. Colburn, R. W.; Lubin, M. L.; Stone, D. J.; Wang, Y.; Lawrence, D.; D'Andrea, M. R.; Brandt, M. R.; Liu, Y, Flores, C. M.; Qin, N. Attenuated cold sensitivity in TRPM8 null mice. Neuron, 2007, 54, 379-86.
35. Dhaka, A.; Murray, A. N.; Mathur, J.; Earley, T. J.; Petrus, M. J.; Patapoutian, A. TRPM8 is required for cold sensation in mice. Neuron, 2007, 54, 371-378.
36. Jensen, T. S.; Gottrup, H.; Sindrup, S. H.; Bach, F. W. The clinical picture of neuropathic pain. Eur. J. Pharmacol., 2001, 429, 1-11.
37. Namer, B.; Seifert, F.; Handwerker, H. O.; Maihöfner, C. TRPA1 and TRPM8 activation in humans: effects of cinnamaldehyde and menthol. Neuroreport, 2005, 16, 955-959.
38. Seebacher, F.; Murray, S. A. Transient receptor potential ion channels control thermoregulatory behaviour in reptiles. PLoS One, 2007, 2, e281.
39. Ruskin, D. N.; Anand, R.; LaHoste, G. J. Menthol and nicotine oppositely modulate body temperature in the rat. Eur. J. Pharmacol., 2007, 559, 161-164.
40. Tajino, K.; Matsumura, K.; Kosada, K.; Shibakusa, T.; Inoue, K.; Fushiki, T.; Hosokawa, H.; Kobayashi, S. Application of menthol to the skin of whole trunk in mice induces autonomic and behavioral heat-gain responses. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 293, R2128-2135.
41. Masamoto, Y.; Kawabata, F.; Fushiki, T. Intragastric administration of TRPV1, TRPV3, TRPM8, and TRPA1 agonists modulates autonomic thermoregulation in different manners in mice. Biosci. Biotechnol. Biochem., 2009, 1021-1027
42. Ding, Z.; Gomez, T.; Werkheiser, J. L.; Cowan, A.; Rawls, S. M. Icilin induces a hyperthermia in rats that is dependent on nitric oxide production and NMDA receptor activation. Eur. J. Pharmacol., 2008, 578, 201-208.
43. Wei, E. T. Inhibition of shaking movements in rats by central administration of cholinergic and adrenergic agents. Psychopharm., 1983, 81, 111-114.
44. Almeida, M. C.; Steiner, A. A.; Branco, L. G. S.; Romanovsky, A. A. Neural Substrate of Cold-Seeking Behavior in Endotoxin Shock. PLoS One, 2006, 1, e1.
45. Mandadi, S.; Nakanishi, S. T.; Takashima, Y.; Dhaka, A.; Patapou-tian, A.; McKemy, D. D.; Whelan, P. J. Locomotor networks are targets of modulation by sensory transient receptor potential vanil-loid 1 and transient receptor potential melastatin 8 channels. Neu-roscience, 2009, 162, 1377-1397.
46. Gavva, N. R.; Treanor, J. J. S.; Garami, A.; Fang, F.; Surapaneni, S.; Akrami, A.; Alvarez, F.; Bak, A.; Darling, M.; Gore, A.; Jang, G. R.; Kesslak, J. P.; Ni, L.; Norman, M. N.; Palluconi, G.; Rose, M. J.; Salfi, M.; Tan, E.; Romanovsky, A. A.; Banfield, C.; Davar, G. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain, 2008, 136, 202-210.
47. Crutchlow, M.; Dong, Y.; Schulz, V.; Von Hoydonck, P.; Laethem, T.; Maes, A.; Larson, P.; Eid, S.; Kane, S.; Hans, G.; Murphy, G.; Chodakewitz, J.; Greenspan, J.; Blanchard, R. Pharmacologic inhibition of TRPV1 impairs sensation of potentially injurious heat in healthy subjects. In American Society for Clinical Pharmacology and Therapeutics 2009 Annual Meeting, National Harbor, Maryland, USA, March 18-21, 2009; LBII-A-3.
48. Romanovsky, A. A.; Almeida, M. C.; Garami, A.; Steiner, A. A.; Norman, M. H.; Morrison, S. F.; Nakamura, K.; Burmeister, J. J.; Nucci, T. B. The Transient Receptor Potential Vanilloid-1 Channel in Thermoregulation: A Thermosensor It Is Not. Pharmacol. Rev., 2009, 61, 228-261.
49. Weil, A.; Moore, S. E.; Waite, N. J.; Randall, A.; Gunthorpe, M. J. Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8. Mol. Pharmacol., 2005, 68, 518-527.
50. De Blas, G. A.; Darszon, A.; Ocampo, A. Y.; Serrano, C. J.; Castel-lano, L. E.; Hernández-González, E. O.; Chirinos, M.; Larrea, F.; Beltrán, C.; Treviño, C. L. TRPM8, a versatile channel in human sperm. PLoS One, 2009, 4, e6095.
51. Beck, E. J.; Hutchinson, T. L.; Qin, N.; Flores, C. M.; Liu, Y. Development and validation of a secondary screening assay for TRPM8 antagonists using QPatch HT. Assay Drug Dev. Technol., 2010, 8, 63-72.
52. Mälkiä, A.; Pertusa, M.; Fernández-Ballester, G.; Ferrer-Montiel, A.; Viana, F. Differential role of the menthol-binding residue Y745 in the antagonism of thermally gated TRPM8 channels. Mol. Pain, 2009, 5, 62-74.
53. Mälkiä A.; Madrid, R.; Meseguer, V.; de la Peña, E.; Valero, M.; Belmonte, C.; Viana, F. Bidirectional shifts of TRPM8 channel gating by temperature and chemical agents modulate the cold sensitivity of mammalian thermoreceptors. J. Physiol., 2007, 581, 155-174.
54. Liu, Y.; Lubin, M. L.; Reitz, T. L.; Wang, Y.; Colburn, R. W.; Flores, C. M.; Qin, N. Molecular identification and functional characterization of a temperature-sensitive transient receptor potential channel (TRPM8) from canine. Eur. J. Pharmacol., 2006, 530, 23-32.
55. Reid, G.; Babes, A.; Pluteanu, F. A cold- and menthol-activated current in rat dorsal root ganglion neurones: properties and role in cold transduction. J. Physiol., 2002, 545.2, 595-614.
56. Behrendt, H. J.; Germann, T.; Gillen, C.; Hatt, H.; Jostock, R. Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. Br. J. Pharmacol., 2004, 141, 737-745.
57. Madrid, R.; Donovan-Rodríguez, T.; Meseguer, V.; Acosta, M. C.; Belmonte, C.; Viana, F. Contribution of TRPM8 channels to cold transduction in primary sensory neurons and peripheral nerve terminals. J. Neurosci., 2006, 26, 12512-12525.
58. Garami, A.; Shimansky, Y. P.; Pakai, E.; Oliveira, D. L.; Gavva, N. R.; Romanovsky, A. A. Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia. J. Neurosci., 2010, 30, 1435-1440.
59. Lehto, S. G.; Tamir, R.; Deng, H.; Klionsky, L.; Kuang, R.; Le, A.; Le, D.; Louis, J. C.; Magal, E.; Manning, B. H.; Rubino, J.; Sura-paneni, S.; Tamayo, N.; Wang, T.; Wang, J.; Wang, J.; Wang, W.; Youngblood, B.; Zhang, M.; Zhu, D.; Norman, M. H.; Gavva, N. R. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanil-loid type 1 modulator that does not cause hyperthermia in rats. J. Pharmacol. Exp. Ther., 2008, 326, 218-29.
60. Gavva, N. R.; Bannon, A.W.; Surapaneni, S.; Hovland, D. N.; Lehto, S. G.; Gore, A.; Juan, T.; Deng, H.; Han, B.; Klionsky, L.; Kuang, R.; Le, A.; Tamir, R.; Wang, J.; Youngblood, B.; Zhu, D.; Norman, M. H.; Magal, E.; Treanor, J. J. S.; Louis, J. C. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J. Neurosci., 2007, 27, 3366-3374.
61. Suh, Y. G.; Lee, Y. S.; Min, K. H.; Park, O. H.; Seung, H. S.; Kim, H.D.; Park, H. G.; Choi, J. Y.; Lee, J.; Kang, S. W.; Oh, U. T.; Koo, J. Y.; Joo, Y. H.; Kim, S. Y.; Kim, J. K.; Park, Y. H. Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects. Bioorg. Med. Chem. Lett., 2003, 13, 4389-4393.
62. Docherty, R. J.; Yeats, J. C.; Piper, A.S. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. Br. J. Pharmacol., 1997, 121, 1461-1467.
63. Liu, L.; Simon, S. A. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. Neurosci. Lett., 1997, 228, 29-32.
64. Gill, C. H.; Strijbos, P. J.; Bates, S. A.; Cairns, W.; Owen, D.; Davies, C. H. Capsazepine inhibits a recombinant human HCN1-mediated current. Br. J. Pharmacol., 2001, 135, 251P.
65. Wang, Y.; Szabo, T.; Welter, J. D.; Toth, A.; Tran, R.; Lee, J.; Kang, S. U.; Suh, Y. G.; Blumberg, P. M.; Lee, J. High affinity antagonists of the vanilloid receptor. Mol. Pharmacol., 2002, 62, 947-956.
66. Mahmmoud, Y. A. Capsazepine, a synthetic vanilloid that converts the Na,K-ATPase to Na-ATPase. Proc. Nat. Acad. Sci. USA, 2008, 105, 1757-1761.
67. Vincent, F.; Acevedo, A.; Nguyen, M. T.; Dourado, M.; DeFalco, J.; Gustafson, A.; Spiro, P.; Emerling, D. E.; Kelly, M. G.; Dunc-ton, M. A. J. Identification and characterization of novel TRPV4 modulators. Biochem. Biophys. Res. Comm., 2009, 389, 490-494.
68. Savidge, J. R.; Ranasinghe, S. P.; Rang, H. P. Comparison of intra-cellular calcium signals evoked by heat and capsaicin in cultured rat dorsal root ganglion neurons and in a cell line expressing the rat vanilloid receptor, VR1. Neuroscience, 2001, 102, 177-184.
69. McIntyre, P.; McLatchie, L. M.; Chambers, A.; Phillips, E.; Clarke, M.; Savidge, J.; Toms, C.; Peacock, M.; Shah, K.; Winter, J.; Weerasakera, N.; Webb, M.; Rang, H. P.; Bevan, S.; James, I. Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br. J. Pharmacol., 2001, 132, 1084-1094.
70. Seabrook, G. R.; Sutton, K. G.; Jarolimek, W.; Hollingworth, G. J.; Teague, S.; Webb, J.; Clark, N.; Boyce, S.; Kerby, J.; Ali, Z.; Chou, M.; Middleton, R.; Kaczorowski, G.; Jones, A. B. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodores-iniferatoxin. J. Pharmacol. Exp. Ther., 2002, 303, 1052-1060.
71. Bevan, S.; Hothi, S.; Hughes, G.; James, I. F.; Rang, H. P.; Shah, K.; Walpole, C. S.; Yeats, J. C. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol., 1992, 107, 544-552.
72. Ahluwalia, J.; Rang, H.; Nagy, I. The putative role of vanilloid receptor-like protein-1 in mediating high threshold noxious heat-sensitivity in rat cultured primary sensory neurons. Eur. J. Neuro-sci., 2002, 16, 1483-1489.
73. Sauer, S. K.; Reeh, P. W.; Bove, G. M. Noxious heat-induced CGRP release from rat sciatic nerve axons in vitro. Eur. J. Neuro-sci.,2001, 14, 1203-1208.
74. Greffrath, W.; Kirschstein, T.; Nawrath, H.; Treede, R. Changes in cytosolic calcium in response to noxious heat and their relationship to vanilloid receptors in rat dorsal root ganglion neurons. Neurosci-ence, 2001, 104, 539-550.
75. Gavva, N. R.; Tamir, R.; Qu, Y.; Klionsky, L.; Zhang, T. J.; Im-mke, D.; Wang, J.; Zhu, D.; Vanderah, T. W.; Porreca, P.; Doherty, E. M.; Norman, M. H.; Wild, K. D.; Bannon, A. W.; Louis, J. C.; Treanor, J. J. S. AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J. Pharmacol. Exp. Ther., 2005, 313, 474-484.
76. Latorre, R.; Brauchi, S.; Orta, G.; Zaelzer, C.; Vargas, G. Ther-moTRP channels as modular proteins with allosteric gating. Cell Calcium, 2007, 42, 427-438.
77. Bandell, M.; Dubin, A. E.; Petrus, M. J.; Orth, A.; Mathur, J.; Hwang, S. W.; Patapoutian, A. High-throughput random mutagene-sis screen reveals TRPM8 residues specifically required for activation by menthol. Nat. Neurosci., 2006, 9, 493-500.
78. Stary, Z. Stimulation of heat nerves by pharmaceutical substances. Archiv fuer Exp. Pathol. Pharmakol., 1925, 105, 76-87.
79. Bliss, A. R.; Glass, H. B. A chemical and pharmacological comparison of the menthols. J. Am. Pharm. Ass., 1940, 29, 171-175.
80. Hensel, H.; Zotterman, Y. Effect of menthol on the thermorecep-tors. Acta Physiol. Scand., 1951, 24, 27-34.
81. Dodt, E.; Skouby, A. P.; Zotterman, Y. Effect of cholinergic substances on the discharges from thermal receptors. Acta Physiol. Scand., 1953, 28, 101-114.
82. Zotterman, Y. The function of thermoreceptors. Acta Neurovegeta-tiva, 1995, 11, 130-141.
83. Hensel, H.; Andress, K. H.; Düring, M. Structure and function of cold receptors Pflügers Arch., 1974, 352, 1-11.
84. Green, B. G. Menthol inhibits the perception of warmth. Phys. Behav., 1986, 38, 833-838.
85. Lindstrom S; Mazieres L. Effect of menthol on the bladder cooling reflex in the cat. Acta Physiol. Scand., 1991, 141, 1-10.
86. Sekizawa, S.; Tsubone, H.; Kuwahara, M.; Sugano, S. Nasal receptors responding to cold and l-menthol airflow in the guinea pig. Respiration Physiol., 1996, 103, 211-219.
87. Reid, G.; Flonta, M.-L. Cold current in thermoreceptive neurons. Nature, 2001, 413, 480.
88. Viana, F.; De la Pena, E.; Belmonte, C. Specificity of cold thermo-transduction is determined by differential ionic channel expression. Nat. Neurosci., 2002, 5, 254-260.
89. Eccles, R. Menthol and related cooling compounds. J. Pharm. Pharmacol., 1994, 46, 618-630.
90. Watson, H. R.; Hems, R.; Rowsell, D. G. New compounds with the menthol cooling effect. J. Soc. Cosmet. Chem., 1978, 29, 185-200.
91. Macpherson, L. J.; Hwang, S. W.; Miyamoto, T.; Dubin, A. E.; Patapoutian, A.; Story, G. M. More than cool: promiscuous relationships of menthol and other sensory compounds. Mol. Cell. Neu-rosci., 2006, 32, 335-343.
92. Watson, H. W.; Roswell, D. G.; Browning, J. H. D. p-Menthane derivatives with cooling effect. DE2202535 (1972); Chem. Abstr., 1972, 77, 140355.
93. Watson, H. R. 3-Substituted p-menthanes as cooling agents. DE2203947 (1972); Chem. Abstr., 1972, 77, 143740.
94. Watson, H. R. Compositions with cooling effect containing p-menthanediols. DE2203273 (1972); Chem. Abstr., 1972, 77, 143742.
95. Watson, H. R.; Roswell, D. G.; Spring, D. J. p-Menthane-3-carboxamides with physiological cooling effects. DE2205255 (1972); Chem. Abstr., 1973, 78, 43771.
96. Watson, H. R. Substituted p-menthane compositions. GB1315626 (1973); Chem. Abstr., 1973, 79, 57569.
97. Roswell, D. G.; Spring, D. J.; Hems, R. Carboxamides with physiological cooling effects. DE2317538 (1973); Chem. Abstr., 1974, 80, 30610.
98. Roswell, D. G.; Spring, D. J. Stimulants for the cold receptors of the human nervous system. DE2316999 (1973); Chem. Abstr., 1974, 80, 40944.
99. Roswell, D. G.; Gascoye, J. M. Cyclohexanol derivatives with physiological cooling effect. DE2317000 (1973) Chem. Abstr., 1974, 80, 41042.
100. Roswell, D. G.; Gascoyne, J. M.; Hems, R. Cyclohexanecarbox-amides with physiological cooling effects. DE2317539 (1973); Chem. Abstr., 1974, 80, 52286.
101. Roswell, D. G.; Spring, D. J.; Hems, R. Sulfonamides and sulfina-mides with physiological cooling effect. DE2336495 (1974); Chem. Abstr., 1974, 80, 112515.
102. Roswell, D. G.; Spring, D. J.; Hems, R. Sulfones and sulfoxides with physiological cooling effect. DE2334985 (1974); Chem. Abstr., 1974, 80, 112516.
103. Watson, H. R.; Roswell, D. G.; Spring, D. J. Menthane derivatives as tobacco coolants. GB1351762 (1974); Chem. Abstr., 1974, 81, 47583.
104. Roswell, D. G.; Spring, D. J. Phosphine oxides with stimulating action on the cold receptors of the human nervous system. DE2345156 (1974); Chem. Abstr., 1974, 81, 68561.
105. Roswell, D. G. Cyclohexanecarboxamides. DE2413639 (1974); Chem. Abstr., 1975, 82, 86130.
106. Gascoyne, J. M.; Hems, R.; Spring, D. J. (Cyclo) alkylmethanols as physiological cooling agents. DE2439770 (1975); Chem. Abstr., 1975, 83, 65338.
107. Watson, H. R. Substituted p-menthane compositions having a physiological cooling effect. GB1315626 (1975); Chem. Abstr., 1975, 83, 120674.
108. Roswell, D. G.; Spring, D. J.; Hems, R. Product with physiological cooling effect. DE2458562 (1975); Chem. Abstr., 1975, 83, 136919.
109. Roswell, D. G.; Hems, R. Product with physiological cooling action. DE2516610 (1975); Chem. Abstr., 1976, 84, 49829.
110. Roswell, D. G.; Spring, D. J.; Hems, R. Aliphatic N-substituted tertiary amides possessing physiological cooling activity. GB1421744 (1976); Chem. Abstr., 1976, 84, 150224.
111. Gascoyne, J. M.; Spring, D. J. Composition or article with stimulating action on the cold receptors of the human nervous system. DE2624504 (1976); Chem. Abstr., 1977, 86, 145798.
112. Watson, H. R.; Roswell, D. G.; Browning, J. H. D. Substituted p-menthanes. US4033994 (1977); Chem. Abstr., 1977, 87, 152425.
113. Watson, H. R.; Roswell, D. G.; Browning, J. H. D. Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity. US4059118 (1977); Chem. Abstr., 1978, 88, 60273.
114. Roswell, D. G.; Spring, D. J.; Hems, R. Novel alicyclic carbox-amides having physiological cooling activity. GB1489359 (1977); Chem. Abstr., 1978, 88, 104760.
115. Gascoyne, J. M.; Spring, D. J. Modifying the flavor of flavor-containing ingestible preparations, including tobacco. GB1502756 (1978); Chem. Abstr., 1978, 89, 106206.
116. Watson, H. R.; Roswell, D. G.; Spring, D. J. N-Substituted p-menthane carboxamides. US4150052 (1979); Chem. Abstr., 1980, 92, 181430.
117. Roswell, D. G.; Gascoyne, J. M.; Hems, R. Cyclohexanecarbox-amides having a physiological cooling effect. US4296093 (1981); Chem. Abstr., 1982, 96, 68444.
118. Bödding, M.; Wissenbach, U.; Flockerzi, V. Characterisation of TRPM8 as a pharmacophore receptor. Cell Calcium, 2007, 42, 618-628.
119. Wei, E. T. Compositons for TRP-M8 binding and radioreceptor methods therewith. US2004161751 (2004); Chem. Abstr., 2004, 141, 170045.
120. Wei, E. T. Ophthalmic compositions and method for treating eye discomfort and pain. US2005059639 (2005); Chem. Abstr., 2005, 142, 303645.
121. Wei, E. T. Radioligands for the trp-m8 receptor and methods therewith. US2005084447 (2005); Chem. Abstr., 2005, 142, 369928.
122. Wei, E. T. A preparation of aryl derivatives of cycloalkanes and alkylcarboxylic acids, useful as analgesics. US2005159394 (2005); Chem. Abstr., 2005, 143, 133392.
123. Wei, E. T. N-(Substituted-aryl-alkyl)-cycloalkyl carboxamide compositions and use in treating skin and sensory disorders. US2005187211 (2005); Chem. Abstr., 2005, 143, 242030.
124. Wei, E. T. Preparation of N-p-menthoyl amino acid esters and amino lactones having skin cooling properties. WO2006103401 (2006); Chem. Abstr., 2006, 145, 397781.
125. Wei, E. T. Radioligands for the trp-m8 receptor and methods therewith. US2007053834; Chem. Abstr., 2007, 146, 290554.
126. Wei, E. T. N-Aryl-hydroxyalkylidene-carboxamide compositions useful for treatment of itching, coughing and pain. US2007155755 (2007); Chem. Abstr., 2007, 147, 150797.
127. Wei, E. T. Synthesis of N-alkylcarbonyl-D-amino hydroxyalkyl ester compounds and their pharmaceutical use. WO2008056119 (2008); Chem. Abstr., 2008, 148, 562175.
128. Wei, E. T. N-alkylcarbonyl-amino acid ester and N-alkylcarbonyl-amino lactone compounds and their use for alleviating irritation, itch, and pain discomforts, and in treatment of cough and/or asthma. US2008227857 (2008); Chem. Abstr., 2008, 149, 362950.
129. Wei, E. T. P-menthane-3-carboxylic acid esters for the treatment of airways diseases. WO2009081107 (2009); Chem. Abstr, 2009, 151, 116626.
130. Wei, E. T. p-Menthane-3-carboxylic acid compounds and their use for the treatment of sensory discomfort such as itch and pain. US2010041757 (2010); Chem. Abstr., 2010, 152, 279587.
131. Podesva, C.; Do Nascimento, J. 1,2,3,6-Tetrahydro-2-pyrimidinones. DE2142385 (1972); Chem. Abstr., 1972, 77, 5510.
132. Wei, E. T. AG-3-5: a chemical which produces sensations of cold. J. Pharm. Pharmacol., 1983, 35, 110-112.
133. Wei, E. T. Chemical stimulants of shaking behavior. J. Pharm. Pharmacol., 1976, 28, 722-724.
134. Wei, E. T. Pharmacological aspects of shaking behavior produced by TRH, AG-3-5, and morphine withdrawl. Federation Proceedings, 1981, 40, 1491-1496.
135. Foster, A.; Van der Logt, C. P. E.; Taleilus, E. W. Tetrahydro-pyrimidine-2-one derivatives and their uses, particularly for producing a cooling sensation, and application to oral and personal hygiene products and foodstuffs. WO2004026840 (2004); Chem. Abstr., 2004, 140, 303686.
136. Dendreon initiates Phase 1 clinical trial of small molecule targeting TRPM8 in cancer. Press release from Dendreon; See http://www.dendreon.com
137. See http://www.clinicaltrials.gov (search D3263).
138. Dendreon presents preclinical data validating anti-tumor activity of D-3263, a Trp-p8 agonist. Press release from Dendreon; See http://www.dendreon.com
139. Dendreon presents preclinical data demonstrating activity of Trp-p8 agonist, D-3263, in benign prostatic hyperplasia. Press release from Dendreon; See http://www.dendreon.com
140. Natarajan, S. K.; Moreno, O.; Graddis, T. J.; Duncan, D.; Laus, R.; Chen, F. Compositions and methods using small mol. Trp-p8 modulators for the treatment of diseases associated with Trp-p8 expression. WO2005020897 (2005); Chem. Abstr., 2005, 142, 291339.
141. Moreno, O.; Natarajan, S.; Duncan, D. F. Preparation of menthyl-carbonylbenzimidazolones and related compounds modulators of Trp-p8 (transient receptor potential-p8) activity. WO2007095340 (2007); Chem. Abstr., 2007, 147, 301173.
142. Moreno, O.; Natarajan, S.; Duncan, D. F. Small-molecule modulators of Trp-p8 activity. US2008255185 (2008); Chem. Abstr., 2008, 149, 471673.
143. Moreno, O.; Natarajan, S.; Duncan, D. F. Small-molecule modulators of Trp-p8 activity. WO2009067410 (2009); Chem. Abstr., 2009, 151, 8757.
144. Reynolds, M.; Polakis, P. Trp-p8 active compounds and therapeutic treatment methods. WO2005002582 (2005); Chem. Abstr., 2005, 142, 127562.
145. Plath, T.; Reule, M.; Kaiser, S. Use of a TRPM8-activating substance for the treatment of tumors. WO2004054497 (2004); Chem. Abstr., 2004, 141, 65083.
146. Gunthorpe, M. J.; Hannan, S. L.; Smart, D.; Jerman, J. C.; Arpino, S.; Smith, G. D.; Brough, S.; Wright, J.; Egerton, J.; Lappin, S. C.; Holland, V. A.; Winborn, K.; Thompson, M.; Rami, H. K.; Randall, A.; Davis, J. B. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor. J. Pharmacol. Exp. Ther., 2007, 321, 1183-1192.
147. Kraft, R.; Grimm, C.; Frenzel, H.; Harteneck, C. Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Brit. J. Pharmacol., 2006, 148, 264-273.
148. On a broader front, it would also be desirable to evaluate compounds synthesized as inhibitors of ion-channels against the full panopoly of TRP channels. Such an endeavor would yield important SAR information and provide researchers with a TRP agonist and antagonist heat map. This exercise would also be valuable in providing proof-of-concept probe molecules against less well investigated TRP family members, and perhaps yield compounds that are suitable as both in vitro and in vivo tool compounds.
149. Meseguer, V.; Karashima, Y.; Talavera, K.; D'Hoedt, D.; Donovan-Rodriguez, T.; Viana, F.; Nilius, B.; Voets, T. Transient receptor potential channels in sensory neurons are targets of the antimycotic agent clotrimazole. J. Neurosci., 2008, 28, 576-586.
150. Hill, K.; McNulty, S.; Randall, A. D. Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole. Arch. Pharmacol., 2004, 370, 227-237.
151. Nilius B.; Prenen J.; Vennekens R.; Hoenderop J. G.; Bindels R. J.; Droogmans G. Pharmacological modulation of monovalent cation currents through the epithelial Ca2+ channel ECaC1. Brit. J. Pharmacol., 2001, 134, 453-462.
152. Lampe, T.; Alonso-Alija, C.; Stelte-Ludwig, B.; Sandner, P.; Bau-ser, M.; Beck, H.; Lustig, K.; Rosentreter, U.; Stahl, E.; Takagi, H. Preparation of substituted N-(4-benzyloxyphenyl)methylamide de-rivs. as cold menthol receptor-1 (CMR-1) antagonists for treatment of urological disorders. WO2006040136 (2006); Chem. Abstr., 2006, 144, 412353.
153. Lampe, T.; Alonso-Alija, C.; Bauser, M.; Beck, H.; Rosentreter, U.; Sandner, P.; Stahl, E.; Stelte-Ludwig, B. Preparation of substituted 4-benzyloxy-benzoic acid amide derivatives as Cold Menthol Receptor 1 (CMR-1) modulators for treating and preventing urol. diseases or disorders. WO2007017092 (2007); Chem. Abstr., 2007, 146, 251609.
154. Lampe, T.; Alonso-Alija, C.; Beck, H.; Rosentreter, U.; Sandner, P.; Stahl, E.; Stelte-Ludwig, B. Preparation of substituted 2-benzyloxy-benzoic acid amide derivatives as Cold Menthol Receptor 1 (CMR-1) modulators for treating and preventing urol. diseases or disorders. WO2007017093 (2007); Chem. Abstr., 2007, 146, 251610.
155. Lampe, T.; Alonso-Alija, C.; Beck, H.; Rosentreter, U.; Sandner, P.; Stahl, E.; Stelte-Ludwig, B. Preparation of substituted benzy-loxy-phenylmethylcarbamate derivatives as Cold Menthol Receptor 1 (CMR-1) modulators for treating and preventing urol. diseases or disorders. WO2007017094 (2007); Chem. Abstr., 2007, 146, 251617.
156. Lampe, T.; Alonso-Alija, C.; Beck, H.; Rosentreter, U.; Sandner, P.; Stahl, E.; Stelte-Ludwig, B. Substituted benzyloxy-phenylmethylurea derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use as CMR-1 (Cold Menthol Receptor 1) antagonists. WO2007080109 (2007); Chem. Abstr., 2007, 147, 188825.
157. Irlapati, N. R.; Thomas, A.; Kurhe, D. K.; Shelke, S. Y.; Khairat-kar, J. N.; Viswanadha, S.; Mukhopadhyay, I. Preparation of fused oxazole and thiazole derivatives as TRPM8 modulators. WO2010010435 (2010); Chem. Abstr., 2010, 152, 192106.
158. Colburn, R. W.; Dax, S. L.; Flores, C.; Matthews, J.; Qin, N.; Youngman, M. A.; Teleha, C.; Reany, L. Phosphorus-containing benzothiophene and benzofuran antagonists of transient cold receptor potential channels (TRPM8) as antihyperalgesic and antiallo-dynic agents for treatment of abnormal cold sensitivity and pain. WO2007134107 (2007); Chem. Abstr., 2007, 147, 541994.
159. Branum, S. T.; Colburn, R. W.; Dax, S. L.; Flores, C. M.; Jetter, M. C.; Liu, Y.; Ludovici, D.; Macielag, M. J.; Matthews, J. M.; Mcnally, J. J.; Reaney, L. M.; Russell, R. K.; Qin, N.; Wells, K. M.; Youells, S. C.; Youngman, M. A. N-Benzothienyl sulfona-mides as TRPM8 modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2009012430 (2009); Chem. Abstr., 2009, 150, 168153.
160. Barnett, A. G.; Dobson A. J.; McElduff P.; Salomaa V.; Kuulasmaa K.; Sans S. Cold periods and coronary events: an analysis of populations worldwide. J. Epidemiol. Community Health, 2005, 59, 551-557.
161. Acton, P. D.; Hlasta, D. J.; Matthews, J. M.; McNally, J. J. Radio-labelled TRPM8 receptor ligands. WO2010009210 (2010); Chem. Abstr., 2010, 152, 162980.
162. Colburn, R. W.; Dax, S. L.; Flores, C. M.; Ludovici, D. W.; Xia, M.; Xu, X.; Youngman, M. A.; Zhu, B. Amide compounds as cold menthol receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2010021882 (2010); Chem. Abstr., 2010, 152, 287165.
163. Colburn, R. W.; Dax, S. L.; Flores, C. M.; Ludovici, D. W.; Mathews, J. M.; Xia, M.; Xu, X.; Youngman, M. A.; Zhu, B. N-Acylheterocyclic compounds as cold menthol receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2010021878 (2010); Chem. Abstr., 2010, 152, 311477.
164. Nishimura, N.; Norman, M. H.; Tamayo, N.; Tang, P.; Bo, Y. Y. Preparation of condensed piperidine derivatives useful as therapeutic vanilloid receptor ligands. WO2009038812 (2009); Chem. Abstr., 2009, 150, 352123.
165. Norman, M. H.; Bo, Y. Y.; Gore, V. K.; Horne, D.; Kaller, M.; Ma, V. V.; Monenschein, H.; Nguyen, T.; Nishimura, N.; Tamayo, N. Preparation of substituted dihydroisoquinoline derivatives for use as TRP-M8 receptor ligands. WO2009073203 (2009); Chem. Abstr., 2009, 151, 33430.
166. Ortar, G.; De Petrocellis, L.; Morera, L.; Moriello, A. S.; Orlando, P.; Morera, E.; Nalli, M.; Di Marzo, V. (-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential malaststin-8 (TRPM8) channels. Bioorg. Med. Chem. Lett., 2010, 20, 2729-2732.
167. Player, M. R.; Parks, D. J.; Parsons, W.; Meegalla, S. K.; Illig, C. R.; Ballentine, S. K. Heterocyclic benzimidazoles as TRPM8 modulators. US2010093788 (2010); Chem. Abstr., 2010, 152, 470455.